Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
$ 17.29
Key Takeaways
Risk factor
Modest price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Excellent dividends
Data is available to registered users only
Data is available to registered users only
About
Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology...
Company Valuation
Considering past and projected metrics, the stock is moderately 'expensive' compared to its peers.
Data is available to registered users only
Buy
Sell